Erika Ross to hitch the corporate as VP World Scientific & Regulatory, and Sarah Moore to hitch as VP World Advertising

EINDHOVEN, NETHERLANDS, LAUSANNE, Switzerland, and BOSTON, MA USA, January 23, 2023 (GLOBE NEWSWIRE) — ONWARD MEDICAL NV (Euronext: ONWD), a medical expertise firm creating modern therapies to revive motion, independence and well being to folks with spinal wire accidents (SCI), at the moment introduced two necessary appointments to the management workforce to drive the Firm’s scientific analysis and industrial actions. Each new hires will probably be primarily based within the US and can report back to Dave Marver, CEO.

World VP Scientific & New Regulatory – Erika Ross, PhD

Erika Ross will be a part of ONWARD as Vice President, World Scientific & Regulatory, efficient January 23, 2023. On this newly created position, Erika will assume international duty for ONWARD’s scientific and regulatory actions.

Erika joins ONWARD from Abbott Neuromodulation, the place she was director, World Scientific & Utilized Analysis. Beforehand, as Director of Neuroscience at Cala Well being, he managed the scientific analysis program that led to the de novo clearance and launch of the corporate’s neurostimulation expertise. Erika additionally serves as Deputy Director, Medical System Innovation Accelerator, Division of Surgical procedure and Assistant Professor, Division of Neurological Surgical procedure at Mayo Clinic. Erika holds a BSc in Biology and Enterprise and an MSc in Molecular Biology from the College of Denver, and a PhD in Neuroscience from the Mayo Clinic.

“I’m excited to welcome Erika to our management workforce,” mentioned Dave Marver, Chief Government Officer. “Her deep experience in neuromodulation will strengthen our firm as we put together to commercialize the numerous promising therapies in our pipeline. Erika additionally brings distinctive relationships with researchers and physicians, cast over a few years of labor in neuroscience and neurosurgery on the Mayo Clinic and persevering with after her transfer to trade.

“I’m pleased with the chance to assist ONWARD remedy deal with a crucial unmet want for folks with spinal wire accidents. I’m additionally excited to hitch this passionate and extremely succesful management workforce, who’re pushed to carry this necessary remedy to life as shortly as doable.” commented Erika Ross.

New VP, World Advertising – Sarah Moore

Sarah Moore will be a part of ONWARD as Vice President, World Advertising, efficient February 1, 2023. On this position, Sarah will probably be accountable for ONWARD’s international advertising and marketing operations, together with product administration and launch planning.

Sarah involves ONWARD from Nevro, an implantable neuromodulation firm, the place she was Head of Industrial Advertising. Beforehand, he held a number of management roles in international advertising and marketing throughout a number of Johnson & Johnson medical system franchises, most just lately as enterprise unit chief for J&J’s Superior Imaging enterprise. Sarah obtained an MBA from Duke College and a BA in German from Washington and Lee College.

“Sarah’s in depth background in medical system advertising and marketing, and neuromodulation therapies specifically, will probably be invaluable as we put together to commercialize our first remedy later this 12 months,” mentioned Dave Marver. “He brings a wealth of capabilities that reach past advertising and marketing that can assist us scale.”

“I’m impressed by ONWARD’s mission, and it’s an honor to hitch this world-class workforce targeted on restoring operate to folks with spinal wire accidents. I sit up for working with the scientific group to carry this game-changing remedy to market,” added Sarah Moore.

About ONWARD Medical

ONWARD is a medical expertise firm that creates modern therapies to revive motion, independence, and well being to folks with spinal wire accidents. ONWARD’s work builds on greater than a decade of primary science and preclinical analysis carried out on the earth’s main neuroscience laboratories. ONWARD’s ARC Remedy, which may be delivered by way of an implantable (ARC-IM) or exterior (ARC-EX) system, is designed to ship focused spinal wire stimulation, programmed to revive motion and different capabilities in folks with spinal wire accidents, in the end enhancing their . high quality of life.

ONWARD has obtained 5 Breakthrough System Designations from the US FDA together with ARC-IM and ARC-EX. ARC-EX is an exterior, non-invasive platform consisting of a wearable stimulator and a wi-fi programmer. Constructive top-line information was reported in 2022 from the corporate’s first pivotal research, referred to as Up-LIFT, evaluating the flexibility of transcutaneous ARC Remedy to enhance higher extremity power and performance. The corporate is at present making ready to submit advertising and marketing approvals for the US and Europe. ARC-IM consists of an implantable pulse generator and leads positioned close to the backbone. The corporate has accomplished the primary use of the ARC-IM neurostimulator in 2022.

ONWARD is headquartered in Eindhoven, the Netherlands. It maintains a Science and Engineering Middle in Lausanne, Switzerland, and has a rising US presence in Boston, Massachusetts. The corporate has an educational partnership with .NeuroRestore, a collaboration between the Swiss Federal Institute of Know-how (EPFL) and the Lausanne College Hospital (CHUV). For extra details about the corporate, please go to To entry our 2023 Monetary Calendar, please go to

For Firm Inquiries:

For Media Inquiries:
MC Providers AG
USA: Laurie Doyle, P: +1 339 832 0752
Europe: Dr. Johanna Kobler, Katja Arnold, Kaja Skorka, P: +49 89 210 228 0

For Investor questions:


Sure statements, beliefs and opinions on this press launch are forward-looking, which mirror the Firm or, as acceptable, the expectations and forecasts of the Firm’s administrators relating to future occasions. By their nature, forward-looking statements contain varied dangers, uncertainties and assumptions that would trigger precise outcomes or occasions to vary materially from these expressed or implied by the forward-looking statements. These dangers, uncertainties and assumptions could adversely have an effect on the outcomes and monetary results of the plans and occasions described herein. Many components together with, however not restricted to, adjustments in demand, competitors, and expertise, might trigger precise occasions, efficiency, or outcomes to vary materially from anticipated developments. Ahead-looking statements contained on this press launch relating to previous tendencies or actions shouldn’t be construed as representations that such tendencies or actions will proceed sooner or later. In consequence, the Firm expressly disclaims any obligation or obligation to subject updates or revisions to forward-looking statements on this press launch because of adjustments in expectations or any adjustments in occasions, situations, assumptions, or circumstances on which these forward-looking statements are primarily based. Neither the Firm nor its advisors or representatives or any of its subsidiaries or officers or workers of such individuals warrant that the assumptions contained within the forward-looking statements are free from error or settle for any duty for the accuracy of the longer term statements. statements contained on this press launch or the precise prevalence of forecasted developments. You shouldn’t place undue reliance on forward-looking statements, which converse solely as of the date of this press launch.

Primary logo

Supply hyperlink